About
QuidelOrtho Corporation is a prominent global in vitro diagnostics (IVD) company formed from the merger of Quidel Corporation and Ortho Clinical Diagnostics. With over 120 years of combined experience, the company specializes in developing, manufacturing, and marketing a wide range of diagnostic products and services for healthcare providers around the world. QuidelOrtho's offerings include lateral flow assays for infectious diseases and reproductive health, direct fluorescent antibody tests, micro-titer production for bone and complement pathway diagnostics, and fluorescent immunoassay products like the Sofia platform. The company also provides molecular diagnostic products, such as the AmpliVue brand, for pathogen detection. Its products are utilized in hospitals, clinical laboratories, and point-of-care settings, enhancing the speed and accuracy of diagnoses. The company has expanded its capabilities through strategic acquisitions and continues to invest in research and development to uphold its leadership in rapid diagnostic testing. QuidelOrtho is publicly traded on Nasdaq under the symbol QDEL.
Technologies
Keywords
Company Information
-
Employees 6600
-
Founded 1979
-
Annual Revenue $2764000000
-
Total Funding $71000000
Location
9975 Summers Ridge Rd, San Diego, California, United States, 92121
